EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
By C. Aninat, A. Piton, D. Glaise, T. Le Charpentier, S. Langouët, F. Morel, C. Guguen-Guillouzo, A. Guillouzo. Drug Metabolism And Disposition, 2006
705 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/8773afc310a1cbdea9e402d8c7a51f596d4947c0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Hengstler
- N. Hewitt
- G. Tuschl
- María J Gómez Lechón
- Albert P. Li
- P. Maurel
- J. Kenna
- J. Houston
Citations in the corpus
- Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies (2007, background): “Recent advances in hepatocyte-like cell lines have been obtained by the use of HepaRG cells derived from a human hepatocellular carcinoma (Aninat et al., 2006; Gripon et al., 2002).”